Teijin To Solidify Ortho Biz With Bone-Fixation Investment
Executive Summary
Japan's Teijin is adding a family of bioresorbable, osteosynthetic bone-fixation devices to its modest but growing orthopedics portfolio.
You may also be interested in...
Teijin Nakashima Doubles Down On Spine And Trauma In Japan
In a deal with Otsuka, Teijin has agreed to acquire KiSCO’s spine and trauma operations, commencing February 2021.
Market Intel: Market Dynamics Switchover To Come In Fast-Growing Soft Tissue Fixation Segment
Global sales for arthroscopy and sports medicine devices are predicted to hit $6.5bn by 2021. This will be driven by the fast-growing soft tissue fixation products segment: significant changes in market dynamics are expected over the next few years, as hip fixation procedures pick up pace. This article delves into the landscape of the soft tissue fixation device market, as well as the four key segments in the arthroscopy devices space. It will also analyze the key players in these markets, highlight trends and discuss the biggest challenges.
M&A Analysis: Feeble Start To 2017
2017 kicked off with 12 medtech M&A acquisitions in January, a decline from the 18 M&A deals recorded in the same month last year, and two fewer than the previous month.